Market Place
Sourcing Support
All News #Library
Biotech
Elevation Oncology Reports Q1 2025 Financial Results and Updates
15 May 2025 //
PR NEWSWIRE
Elevation Presents Preclinical Data for EO-1022 at AACR 2025
25 Apr 2025 //
PR NEWSWIRE
Elevation drops sole clinical-stage ADC, lays off 70% of staff
21 Mar 2025 //
PRNEWSWIRE
Elevation Oncology Halts EO-3021 Development, Focuses on EO-1022
20 Mar 2025 //
PR NEWSWIRE
Elevation Oncology Updates On ADC Programs And Key Milestones
13 Jan 2025 //
PR NEWSWIRE
Elevation lifts HER3 ADC toward clinic with $368M Synaffix deal
12 Dec 2024 //
FIERCE BIOTECH
Elevation Oncology Presents EO-3021 Combo Data at ESMO Congress
05 Dec 2024 //
PR NEWSWIRE
Elevation Oncology Gets FDA Fast Track For EO-3021 In Cancer
23 Sep 2024 //
PR NEWSWIRE
Elevation Oncology Announces Planned Combination Strategy for EO-3021
27 Jun 2024 //
PR NEWSWIRE
Elevation Oncology Presents Preclinical Data for HER3-ADC Program at AACR
08 Apr 2024 //
PR NEWSWIRE
Elevation to Present Preclinical Proof-of-Concept Data for HER3-ADC Program
05 Mar 2024 //
PR NEWSWIRE
Elevation Announces First Patient Dosed in the Phase 1 Trial Evaluating EO-3021
16 Aug 2023 //
PR NEWSWIRE
Elevation Oncology Highlights Clinical Data for SYSA1801 (EO-3021)
26 Apr 2023 //
PR NEWSWIRE
Elevation Oncology Presents EO-3021 Preclinical Proof-of-Concept & Highlights
17 Apr 2023 //
PR NEWSWIRE
Elevation Oncology to Present at the AACR Annual Meeting 2023
14 Mar 2023 //
PR NEWSWIRE
Elevation Oncology Announces Pipeline Prioritization, Realignment of Resources
06 Jan 2023 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.